FDA warns Span­ish drug and API man­u­fac­tur­er over mul­ti­ple pro­duc­tion line prob­lems

The FDA de­liv­ered a laun­dry list of cit­ed prob­lems to a Eu­ro­pean man­u­fac­tur­er with pro­duc­tion line is­sues that in­clud­ed mi­cro­bi­o­log­i­cal con­t­a­m­i­na­tion and im­prop­er clean­ing pro­ce­dures …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER